Flow Cytometry, Extracellular: HEK-293F cells transiently transfected with human CTLA4 were stained with CTLA4 Monoclonal Antibody (CSB0022) (green) or isotype control antibody (gray), followed by AlexaFluor 647- conjugated anti-Mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with CTLA4 Monoclonal Antibody (CSB0022) (blue).

CTLA-4 MAb - CSB0022

Catalog #: CSB0022
Extracellular epitope: Yes
Applications: FC   IF   ICC   ELISA   WB  
Reactivity: Human (Others untested)
Size: 100 µg
Detergent Compatibility: Triton X-100 (0.1%)
Fixative Compatibility: Paraformaldehyde (4%)
Concentration: 1 mg/ml
Isotype: IgG2a
Technical Data Sheet
Safety Data Sheet
$475.00
Adding to cart… The item has been added
  • Description
Description
Application Conditions Recommended Concentration
Flow Cytometry, Extracellular Live, Unpermeabilized 1 µg/ml
HEK-293F cells transiently transfected with CTLA4 were stained with CTLA4 Monoclonal Antibody (CSB0022) (green) or isotype control antibody (gray), followed by AlexaFluor 647- conjugated anti- IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with CTLA4 Monoclonal Antibody (CSB0022) (blue).
Application Conditions Recommended Concentration
Immunofluorescence, Extracellular Fixed 4% paraformaldehyde 1 µg/ml
(Left) JS-1 cells transiently transfected CTLA4 were stained with CTLA4 Monoclonal Antibody (CSB0022) followed by AlexaFluor 647 anti- IgG secondary antibody (red) and DAPI (blue). (Top right) JS-1 cells transiently transfected with an empty control vector stained with CTLA4 Monoclonal Antibody. (Bottom right) Isotype control: JS-1 cells transfected with CTLA4 and stained with control MAb.
Application Conditions Recommended Concentration
Immunofluorescence, Intracellular Fixed 4% paraformaldehyde, Permeabilized 0.1% Triton X-100 1 µg/ml
(Left) JS-1 cells transiently transfected CTLA4 were permeabilized and stained with CTLA4 Monoclonal Antibody (CSB0022) followed by AlexaFluor 647 anti- IgG secondary antibody (red) and DAPI (blue). (Top right) JS-1 cells transiently transfected with an empty control vector stained with CTLA4 Monoclonal Antibody. (Bottom right) Isotype control: JS-1 cells transfected with {{target} and stained with control MAb.
Application Conditions Recommended Concentration
Membrane Proteome Specificity
The specificity of CTLA4 Monoclonal Antibody (CSB0022) was tested on the Membrane Proteome Array™ and shown to be specific for CTLA4. The Membrane Proteome Array™ contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array™ represents the industry standard for determining the binding specificity of antibodies and other protein ligands.

CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies in-house so that you can confidently choose the right antibody for your assay. All antibodies are VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and SPECIFIC in binding to only your target.

Target CTLA4
Target Aliases CD152, GSE, CD, CELIAC3, IDDM12, ALPS5, GRD4
Isotype IgG2a
Species Reactivity Human (Others untested)
Concentration 1 mg/ml

Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.

CTLA-4 is a member of the immunoglobulin superfamily that contains a V domain, a transmembrane domain, and a cytoplasmic tail and has a membrane-bound isoform and a soluble isoform. The membrane-bound isoform is a homodimer, while the soluble isoform is a monomer. CTLA-4 transmits an inhibitory signal to T-cells, and mutations in CTLA-4 are associated with type 1 diabetes, Graves’ disease, Hashimoto thyroiditis, celiac disease, lupus, thyroid-associated orbitopathy, and other autoimmune diseases.

Circle Icon